Association of hemicolectomy with survival in stage II colorectal cancer: a retrospective cohort study
- PMID: 38001388
- DOI: 10.1007/s13304-023-01646-w
Association of hemicolectomy with survival in stage II colorectal cancer: a retrospective cohort study
Abstract
To compare the oncological survival outcomes of partial colectomy (PC) and hemicolectomy (HC) in patients with stage II colon cancer. A total of 18,795 patients with stage II colon cancer who underwent hemicolectomy (n = 12,022) or partial colectomy (n = 6773) from 2010 to 2019 were included in the the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and cancer-specific survival (CSS) were compared between the two groups, and the threshold of harvested lymph nodes was determined. The results showed that age, gender, race, tumor site, scope of regional lymph nodes, postoperative chemotherapy, postoperative radiotherapy, harvested lymph nodes, and tumor size were significantly different between the PC and HC groups (all P < 0.05). The OS rate was slightly lower in hemicolectomy patients than in partial colectomy patients (69.9% vs. 74.5%, respectively, P < 0.001), but CSS was similar between the two groups (87.9% vs. 88.1%, respectively, P = 0.32). After propensity score matching (PSM) was performed, the OS and CSS rates in the two groups were significantly different (CSS 84.3% vs. 88.0%, P < 0.001; OS 62.2% vs. 72.5%, P < 0.001). The survminer R package determined that the optimum threshold for the harvested lymph node count in stage II colon cancer patients was 16. CSS was significantly different between patients with ≥ 12 lymph nodes harvested and patients with ≥ 16 lymph nodes harvested (P = 0.043). Univariate and multivariate Cox regression and survival analyses of stage II colon cancer patients showed that the survival benefit of stage II colon cancer patients receiving partial colectomy was superior to that of patients receiving hemicolectomy. Partial colectomy has significant oncological benefits over hemicolectomy in the treatment of stage II colon cancer patients, even in the case of pT4b or tumor deposits. Removal of 16 lymph nodes during colectomy for stage II colon cancer correlated with improved survival, and this threshold was more effective than the standard threshold of 12 lymph nodes in distinguishing between patients with good and poor prognoses.
Keywords: Cancer-specific survival; Hemicolectomy; Overall survival; Partial colectomy; Stage II colon cancer.
© 2023. Italian Society of Surgery (SIC).
Similar articles
-
Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.Surg Oncol. 2016 Sep;25(3):158-63. doi: 10.1016/j.suronc.2016.05.013. Epub 2016 May 20. Surg Oncol. 2016. PMID: 27566017
-
Extended procedure has no oncological benefits over segmental resection in the treatment of non-metastatic splenic flexure colon cancer, a population-based cohort study and a single center's decade-long experience.Updates Surg. 2024 Aug;76(4):1289-1299. doi: 10.1007/s13304-024-01897-1. Epub 2024 May 31. Updates Surg. 2024. PMID: 38822222
-
Lymph Node Mapping in Transverse Colon Cancer Treated Using Laparoscopic Colectomy With D3 Lymph Node Dissection.Dis Colon Rectum. 2022 Mar 1;65(3):340-352. doi: 10.1097/DCR.0000000000002108. Dis Colon Rectum. 2022. PMID: 35138285
-
Which is the appropriate surgical procedure for appendiceal adenocarcinoma: appendectomy, partial colectomy or right hemicolectomy?Clin Transl Oncol. 2024 Jan;26(1):297-307. doi: 10.1007/s12094-023-03259-6. Epub 2023 Jun 27. Clin Transl Oncol. 2024. PMID: 37368199
-
Right-side colectomy with complete mesocolic excision vs conventional right-side colectomy in the treatment of colon cancer: a systematic review and meta-analysis.Int J Colorectal Dis. 2021 Sep;36(9):1885-1904. doi: 10.1007/s00384-021-03951-5. Epub 2021 May 13. Int J Colorectal Dis. 2021. PMID: 33983451
Cited by
-
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage.J Gastrointest Oncol. 2025 Feb 28;16(1):115-127. doi: 10.21037/jgo-24-576. Epub 2025 Jan 6. J Gastrointest Oncol. 2025. PMID: 40115935 Free PMC article.
-
Predicting treatment failure in stage III colon cancer patients after radical surgery.Front Oncol. 2024 May 16;14:1397468. doi: 10.3389/fonc.2024.1397468. eCollection 2024. Front Oncol. 2024. PMID: 38817900 Free PMC article.
References
-
- Salibasic M, Pusina S, Bicakcic E, Pasic A, Gavric I, Kulovic E et al (2019) Colorectal cancer surgical treatment, our experience. Med Arch 73(6):412–414. https://doi.org/10.5455/medarh.2019.73.412-414 - DOI - PubMed - PMC
-
- PD Simmonds, L Best, S George, et al (2000) Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 356(9234):968–974
-
- Huang J, Huang Q, Tang R, Chen G, Zhang Y, He R (2020) Hemicolectomy does not provide survival benefit for right-sided mucinous colon adenocarcinoma. Front Oncol 10:608836. https://doi.org/10.3389/fonc.2020.608836 - DOI - PubMed
-
- Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y et al (2003) Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46(2):160–167. https://doi.org/10.1007/s10350-004-6518-0 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous